Exact Sciences Cor
(EXAS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EXAS | INCY | RVMD | ||
| Company | Exact Sciences Cor | Incyte Corp | Revolution Medicines Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 102.52 | 102.75 | 97.96 | ||
| High | 102.70 | 104.40 | 98.64 | ||
| Low | 102.48 | 102.45 | 96.22 | ||
| Latest | 102.65 | 104.01 | 96.77 | ||
| Change | +0.15 | +1.34 | -0.39 | ||
| % Change | +0.15% | +1.31% | -0.40% | ||
| Volume | 217,017 | 88,848 | 298,172 | ||
| 20-Day Average Volume | 2,245,745 | 1,877,408 | 5,603,682 | ||
| Previous Close | 102.50 | 102.67 | 97.16 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 102.25 | 104.35 | 108.24 | ||
| 20-Day Raw Stochastic | 94.12% | 41.29% | 40.88% | ||
| 20-Day Relative Strength | 79.72 | 53.69 | 51.71 | ||
| Weighted Alpha | +68.29 | +49.82 | +100.85 | ||
| Today's Opinion | 100% Buy | 88% Buy | 80% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 80% Buy | ||
| Last Month's Opinion | 100% Buy | 80% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.24% since 01/27/26 | +0.50% since 01/27/26 | -2.96% since 01/27/26 | ||
| Low | 102.11 on 01/29/26 | 98.85 on 01/28/26 | 95.30 on 02/02/26 | ||
| High | 102.60 on 02/03/26 | 104.40 on 02/03/26 | 100.30 on 01/28/26 | ||
| 1-Month | |||||
| %Chg | +0.84% since 01/02/26 | +2.53% since 01/02/26 | +22.58% since 01/02/26 | ||
| Low | 101.51 on 01/05/26 | 98.85 on 01/28/26 | 76.28 on 01/05/26 | ||
| High | 102.65 on 01/22/26 | 112.29 on 01/07/26 | 124.49 on 01/16/26 | ||
| 3-Month | |||||
| %Chg | +53.17% since 11/03/25 | +2.38% since 11/03/25 | +63.26% since 11/03/25 | ||
| Low | 64.92 on 11/07/25 | 93.54 on 12/12/25 | 57.74 on 11/04/25 | ||
| High | 102.66 on 12/19/25 | 112.29 on 01/07/26 | 124.49 on 01/16/26 | ||
| 6-Month | |||||
| %Chg | +114.80% since 08/01/25 | +37.57% since 08/01/25 | +164.43% since 08/01/25 | ||
| Low | 38.81 on 08/07/25 | 75.48 on 08/04/25 | 34.00 on 08/07/25 | ||
| High | 102.66 on 12/19/25 | 112.29 on 01/07/26 | 124.49 on 01/16/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 19,527,496 | 19,646,042 | 18,742,374 | ||
| Shares Outstanding, K | 190,810 | 196,323 | 193,320 | ||
| Annual Sales | 2,758,870,000 | 4,241,220,000 | 0 | ||
| Annual Net Income | -1,028,860,000 | 32,610,000 | -600,090,000 | ||
| Last Quarter Sales | 850,740,000 | 1,365,980,000 | 0 | ||
| Last Quarter Net Income | -19,590,000 | 424,170,000 | -305,210,000 | ||
| 60-Month Beta | 1.40 | 0.82 | 0.99 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.24 on 11/03/25 | 2.26 on 10/28/25 | -1.61 on 11/05/25 | ||
| Latest Earnings Date | 02/18/26 | 02/10/26 | 02/25/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 538.42 | 19.00 | 0.00 | ||